Search Results

There are 23367 results for: content related to: Is there a role for targeting vascular endothelial growth factor/receptor axis in the treatment of patients with metastatic melanoma?

  1. Vascular-endothelial-growth-factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer

    Intervention Review

    The Cochrane Library

    Anna Dorothea Wagner, Christoph Thomssen, Johannes Haerting and Susanne Unverzagt

    Published Online : 11 JUL 2012, DOI: 10.1002/14651858.CD008941.pub2

  2. You have free access to this content
    Emerging clinical principles on the use of bevacizumab for the treatment of malignant gliomas


    Volume 116, Issue 17, 1 September 2010, Pages: 3988–3999, Marc C. Chamberlain

    Version of Record online : 19 AUG 2010, DOI: 10.1002/cncr.25256

  3. Angiogenesis inhibitors for the treatment of ovarian cancer

    Intervention Review

    The Cochrane Library

    Kezia Gaitskell, Igor Martinek, Andrew Bryant, Sean Kehoe, Shibani Nicum and Jo Morrison

    Published Online : 7 SEP 2011, DOI: 10.1002/14651858.CD007930.pub2

  4. Impact of bevacizumab on functional recovery and histology of the liver after resection of colorectal metastases


    Volume 98, Issue 3, March 2011, Pages: 399–407, D. A. Wicherts, R. J. de Haas, M. Sebagh, E. Saenz Corrales, D. L. Gorden, F. Lévi, B. Paule, D. Azoulay, D. Castaing and R. Adam

    Version of Record online : 15 DEC 2010, DOI: 10.1002/bjs.7368

  5. Retina, Vitreous

    Clinical & Experimental Ophthalmology

    Volume 36, Issue s1, June 2008, Pages: A459–A584,

    Version of Record online : 18 JUL 2008, DOI: 10.1111/j.1442-9071.2008.01760.x

  6. You have free access to this content
    Anti-vascular endothelial growth factor for neovascular age-related macular degeneration

    Intervention Review

    The Cochrane Library

    Sharon D Solomon, Kristina Lindsley, Satyanarayana S Vedula, Magdalena G Krzystolik and Barbara S Hawkins

    Published Online : 29 AUG 2014, DOI: 10.1002/14651858.CD005139.pub3

  7. You have free access to this content
    Baseline serum albumin is a predictive biomarker for patients with advanced pancreatic cancer treated with bevacizumab: A pooled analysis of 7 prospective trials of gemcitabine-based therapy with or without bevacizumab


    Volume 120, Issue 12, 15 June 2014, Pages: 1780–1786, Shubham Pant, Ludmila K. Martin, Susan Geyer, Lai Wei, Katherine Van Loon, Nilli Sommovilla, Mark Zalupski, Renuka Iyer, David Fogelman, Andrew H. Ko and Tanios Bekaii-Saab

    Version of Record online : 13 MAR 2014, DOI: 10.1002/cncr.28648

  8. You have free access to this content
    Brief-exposure to preoperative bevacizumab reveals a TGF-β signature predictive of response in HER2-negative breast cancers

    International Journal of Cancer

    Volume 138, Issue 3, 1 February 2016, Pages: 747–757, Vinay Varadan, Sitharthan Kamalakaran, Hannah Gilmore, Nilanjana Banerjee, Angel Janevski, Kristy L.S. Miskimen, Nicole Williams, Ajay Basavanhalli, Anant Madabhushi, Kimberly Lezon-Geyda, Veerle Bossuyt, Donald R. Lannin, Maysa Abu-Khalaf, William Sikov, Nevenka Dimitrova and Lyndsay N. Harris

    Version of Record online : 31 AUG 2015, DOI: 10.1002/ijc.29808

  9. You have free access to this content
    Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration

    Intervention Review

    The Cochrane Library

    Lorenzo Moja, Ersilia Lucenteforte, Koren H Kwag, Vittorio Bertele, Annalisa Campomori, Usha Chakravarthy, Roberto D'Amico, Kay Dickersin, Laurent Kodjikian, Kristina Lindsley, Yoon Loke, Maureen Maguire, Daniel F Martin, Alessandro Mugelli, Bernd Mühlbauer, Isabel Püntmann, Barnaby Reeves, Chris Rogers, Christine Schmucker, Manju L Subramanian and Gianni Virgili

    Published Online : 15 SEP 2014, DOI: 10.1002/14651858.CD011230.pub2

  10. You have free access to this content
    A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma


    Volume 119, Issue 3, 1 February 2013, Pages: 586–592, Lisa A. Kottschade, Vera J. Suman, Domingo G. Perez, Robert R. McWilliams, Judith S. Kaur, Thomas T. Amatruda III, Francois J. Geoffroy, Howard M. Gross, Peter A. Cohen, Anthony J. Jaslowski, Matthew L. Kosel and Svetomir N. Markovic

    Version of Record online : 22 AUG 2012, DOI: 10.1002/cncr.27760

  11. The Role of Bevacizumab in the Treatment of Non-Small Cell Lung Cancer: Current Indications and Future Developments

    The Oncologist

    Volume 12, Issue 10, October 2007, Pages: 1183–1193, Cesare Gridelli, Paolo Maione, Antonio Rossi and Filippo De Marinis

    Version of Record online : 1 OCT 2007, DOI: 10.1634/theoncologist.12-10-1183

  12. Toxicity of Bevacizumab in Combination with Chemotherapy in Older Patients

    The Oncologist

    Volume 18, Issue 4, April 2013, Pages: 408–414, Supriya G. Mohile, Molly Hardt, William Tew, Cynthia Owusu, Heidi Klepin, Cary Gross, Ajeet Gajra, Stuart M. Lichtman, Tao Feng, Kayo Togawa, Rupal Ramani, Vani Katheria, Kurt Hansen, Arti Hurria and on Behalf of the Cancer and Aging Research Group

    Version of Record online : 10 APR 2013, DOI: 10.1634/theoncologist.2012-0351

  13. A multi-institutional evaluation of factors predictive of toxicity and efficacy of bevacizumab for recurrent ovarian cancer

    International Journal of Gynecological Cancer

    Volume 18, Issue 3, May/June 2008, Pages: 400–406, J.D. WRIGHT, A.A. SECORD, T.M. NUMNUM, R.P. ROCCONI, M.A. POWELL, A. BERCHUCK, R.D. ALVAREZ, R.K. GIBB, K. TRINKAUS, J.S. RADER and D.G. MUTCH

    Version of Record online : 21 JUL 2007, DOI: 10.1111/j.1525-1438.2007.01027.x

  14. Cost-utility analysis of bevacizumab versus ranibizumab in neovascular age-related macular degeneration using a Markov model

    Journal of Evaluation in Clinical Practice

    Volume 18, Issue 2, April 2012, Pages: 247–255, Jignesh J. Patel, Margaret A.S. Mendes, Mark Bounthavong, Melissa L.D. Christopher, Daniel Boggie and Anthony P. Morreale

    Version of Record online : 16 SEP 2010, DOI: 10.1111/j.1365-2753.2010.01546.x

  15. You have free access to this content
    Early vitreoretinal surgery on vascularly active stage 4 retinopathy of prematurity through the preoperative intravitreal bevacizumab injection

    Acta Ophthalmologica

    Volume 91, Issue 4, June 2013, Pages: e304–e310, Yu Xu, Qi Zhang, Xiaoli Kang, Ying Zhu, Jiakai Li, Yiye Chen and Peiquan Zhao

    Version of Record online : 7 MAY 2013, DOI: 10.1111/aos.12055

  16. Safety, sterility and stability of direct-from-vial multiple dosing intravitreal injection of bevacizumab

    Clinical & Experimental Ophthalmology

    Volume 43, Issue 5, July 2015, Pages: 466–473, Taraprasad Das, Srinivas Volety, Saad M Ahsan, Abhay K Thakur, Savitri Sharma, Tapas R Padhi, Soumyava Basu and Ch Mohan Rao

    Version of Record online : 14 APR 2015, DOI: 10.1111/ceo.12489

  17. Bevacizumab-Based Therapies in the First-Line Treatment of Metastatic Colorectal Cancer

    The Oncologist

    Volume 17, Issue 4, April 2012, Pages: 513–524, John H. Strickler and Herbert I. Hurwitz

    Version of Record online : 3 APR 2012, DOI: 10.1634/theoncologist.2012-0003

  18. You have free access to this content
    Complementary effects of bevacizumab and MMC in the improvement of surgical outcome after glaucoma filtration surgery

    Acta Ophthalmologica

    Volume 93, Issue 7, November 2015, Pages: 667–678, Tine Van Bergen, Evelien Vandewalle, Lieve Moons and Ingeborg Stalmans

    Version of Record online : 18 MAY 2015, DOI: 10.1111/aos.12766

  19. Antiangiogenic Therapy for Cancer: An Update

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 32, Issue 12, December 2012, Pages: 1095–1111, Belal Al-Husein, Maha Abdalla, Morgan Trepte, David L. DeRemer and Payaningal R. Somanath

    Version of Record online : 3 DEC 2012, DOI: 10.1002/phar.1147

  20. Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer

    Intervention Review

    The Cochrane Library

    David Lok Hang Chan, Eva Segelov, Rachel SH Wong, Annabel Smith, Rebecca A Herbertson, Bob T. Li, Niall Tebbutt, Timothy Price and Nick Pavlakis

    Published Online : 27 JUN 2017, DOI: 10.1002/14651858.CD007047.pub2